Několik poznámek k plicní embolii

Jiří Widimský

Cor Vasa 2009, 51(11-12):762-763  

Implantabilní kardiovertery-defibrilátory před čtvrt stoletím a nyní

Alan Bulava

Cor Vasa 2009, 51(11-12):764-766  

current treatment of patients with acute and subacute pulmonary embolism with respect to the newly published guidelines on the diagnosis and treatment of this disease

Aleš Král, Jan Bělohlávek, Vladimír Dytrych, Ondřej Šmíd, Štěpán Havránek, Jan Kaván, Jiří Widimský, Aleš Linhart

Cor Vasa 2009, 51(11-12):767-772 | DOI: 10.33678/cor.2009.190  

Background: Risk stratification and the therapeutic decision process in patients with acute pulmonary embolism (PE) are complicated by lack of clinical data from large prospective randomized trials. The recently published Czech and European guidelines on the diagnosis and treatment of acute PE differ in the nomenclature and certain aspects of risk stratification.Aims: The authors present a hypothetic comparison of both guidelines and the impact of their differences on risk stratification and resulting choice of therapy in a cohort of patients with acute and subacute PE from their institution.Methods: The study was designed as a retrospective...

Percutaneous CoreValve aortic valve implantation-initial clinical experience in high-risk surgical patients at IKEM

Michael Želízko, Jiří Malý, Bronislav Janek, Ivan Netuka, Tomáš Kotulák, Tomáš Marek, Jan Pirk

Cor Vasa 2009, 51(11-12):773-780 | DOI: 10.33678/cor.2009.191  

Background: Percutaneous aortic valve implantation (PAVI) is a recently available technique for interventional treatment of severe aortic stenosis in high-risk surgical patients. We describe our initial clinical experience and short-term (30-day) outcome with percutaneous implantation of the self-expanding CoreValve bioprosthesis.Methods and results: From December 2008 through June 2009, we performed PAVI procedures (third-generation CoreValve ReValving® system prosthesis) in 21 consecutive patients with symptomatic severe aortic stenosis: 8 males and 13 females, aged 80.9 ± 4.8 years, logistic EuroSCORE 17.5 ± 6.9%, mean aortic...

Aortic valve-sparing surgery-early and mid-term outcomes

Jan Vojáček, Martin Tuna, Soňa Vaneková, Jan Dominik, Pavel Žáček, Pavel Polanský, Miroslav Brtko, Pavel Nedbal, Peter Telekes, Jan Harrer

Cor Vasa 2009, 51(11-12):781-788 | DOI: 10.33678/cor.2009.192  

Aim: To determine short- to mid-term outcomes of aortic valve-sparing surgery and aortic valvuloplasty.Methods: A total of 28 aortic valve-sparing surgical and aortic valvuloplasty procedures were performed at the Department of Cardiac Surgery of Hradec Králové University Hospital from November 2007 through June 2009. The mean age of surgical patients was 51 ± 15 years. Preoperatively, the mean degree of aortic regurgitation was 3.5 ± 0.8, ejection fraction (EF) 54 ± 10%, and left ventricular end-diastolic dimension (EDD) 60 ± 10 mm. Overall, functional aortic regurgitation caused by altered aortic root geometry was...

Echocardiographic assessment of left ventricular diastolic function: what we able to do in 2009

Tomáš Paleček, Aleš Linhart

Cor Vasa 2009, 51(11-12):789-804 | DOI: 10.33678/cor.2009.193  

Echocardiographic assessment of left ventricular (LV) diastolic function is constantly evolving as a result of our improving understanding of physiology and pathophysiology of LV diastole and introduction of new ultrasound modalities into routine clinical practice. Because of its comprehensive nature, LV filling analysis represents one of the most challenging tasks to be solved by the echocardiographer. Therefore, the aim of this article is to give a detail review of the current principles of echocardiographic evaluation of LV diastolic function.

Chronic heart failure - focused on women

Alexander Klabník, Ján Murín

Cor Vasa 2009, 51(11-12):805-812 | DOI: 10.33678/cor.2009.194  

The issue of cardiovascular diseases in women is often disregarded. There are significant differences in the epidemiology, morbidity, mortality, diagnosis, etiology, risk factors, comorbidities, in response to pharmacotherapy and non-pharmacological treatment between women and men with chronic heart failure. While this issue has received due attention in developed countries in recent years, no review article on this topic has been published in our journals yet.

Primary tricuspid regurgitation resulting from blunt chest injury sustained in a car accident

Alena Pravečková, Tomáš Paleček, Petr Kuchynka, Jaroslav Lindner, Aleš Linhart

Cor Vasa 2009, 51(11-12):813-816 | DOI: 10.33678/cor.2009.195  

Traumatic tricuspid regurgitation is generally considered a rare complication of blunt non-penetrating chest injury. However, its incidence has been reported to be increasing in recent decades. The most common cause of tricuspid valve trauma injury are road accidents and the higher proportion of car equipped with airbags, with the latter potentially contributing to the mechanism of injury. Impact to the chest may result in various types of the valve chordae, dominated by chordal rupture followed by papillary muscle rupture, and cusp tear. The clinical pattern may thus be most varied-from acute right-heart failure to an asymptomatic course. The current...

Subacute stent thrombosis associated with high residual platelet activity

Martin Malý, Iuri Marinov, Petr Hájek, David Tesař, Ivana Hadačová, Jiří Vejvoda, David Alan, Josef Veselka

Cor Vasa 2009, 51(11-12):817-820 | DOI: 10.33678/cor.2009.196  

Subacute stent thrombosis following percutaneous coronary intervention is a rare complication, yet often with a fatal course. The most common causes of this complication include unrecognized coronary artery dissection, final diameter of the implanted stent and its length, and the increasingly more often discussed individual response to dual antiplatelet treatment. Our report presents a case of recurrent stent thrombosis in coincidence with high residual platelet activity despite dual antiplatelet therapy. The condition was successfully treated with switching the patient from clopidogrel to ticlopidine therapy.

Acute myocardial infarction in a young woman

Martin Kubrycht, Alena Křížová, Ivo Varvařovský, Petr Vojtíšek

Cor Vasa 2009, 51(11-12):821-823 | DOI: 10.33678/cor.2009.197  

Acute myocardial infarction (AMI) belongs to the most serious clinical manifestations of coronary heart disease and is associated with high morbidity and mortality rates, with patients being usually over 45 years old; in younger patients, it occurs less often.According to literary data, the proportion of young patients (< 40 years) is in the range 2-10%. In patients < 30 years, AMI occurs rarely (up to 1% of all cases), with males significantly predominating among the younger age brackets.We report on the case of a young female patient with AMI, probably secondary to accelerated atherosclerosis in the presence of a -cluster of established...

Jaroslav Lindner, Pavel Jansa: Chronická tromboembolická plicní hypertenze

Prof. MUDr. Jan Petrášek, DrSc.

Cor Vasa 2009, 51(11-12):836  

Kardiální varianta Fabryho choroby manifestující se jako hypertrofická kardiomyopatie s těžkou mid-ventrikulární obstrukcí

Tomáš Paleček, Sudheera Magage, Lubor Goláň, Gabriela Dostálová, Milan Elleder, Miroslava Buchtová, Aleš Linhart

Cor Vasa 2009, 51(11-12):824-825 | DOI: 10.33678/cor.2009.198  

Zápis ze schůze výboru ČKS, konané dne 22. září 2009 v Brně

I. Pavézková, L. Klímová, V. Chaloupka

Cor Vasa 2009, 51(11-12):837-838  

Rubrika kardiologických sester

Cor Vasa 2009, 51(11-12):831-832  

Metabolická paměť anebo hříchy minulosti?

Vladimír Staněk

Cor Vasa 2009, 51(11-12):828  

Jubilant prof. MUDr. Michael Aschermann, DrSc., FESC, FACC (21. 11. 1944)

Josef Veselka

Cor Vasa 2009, 51(11-12):829-830  

Prof. William Ganz zemřel 10. listopadu ve věku 90 let

Jiří Widimský, Zbyněk Píša

Cor Vasa 2009, 51(11-12):833  

Nahradí nová antiagregancia clopidogrel?

MUDr. Pavel Jerie

Cor Vasa 2009, 51(11-12):834  

Je dabigatran lepší než warfarin?

MUDr. Pavel Jerie

Cor Vasa 2009, 51(11-12):835  

Edukace pacientů jako základ zlepšení prognózy pacienta s kardiovaskulárním onemocněním

Doc. MUDr. Eliška Sovová, Ph.D., MBA

Cor Vasa 2009, 51(11-12):835  

Kalendář odborných akcí

Cor Vasa 2009, 51(11-12):839-841  

Index of authors

Cor Vasa 2009, 51(11-12):842-849  

Subject index

Cor Vasa 2009, 51(11-12):850-856